Member Directory

Air Products is a market leader in the life science sector and is the only industrial gas company manufacturing liquid nitrogen in the UK that is compliant to the new Medical Device Regulation. As a preferred supplier to One Nucleus, members are entitled to preferential pricing on our standard products, please contact for details. Air Products enables customers across numerous industries to improve their environmental performance, product quality and productivity. We are not only experts in speciality gases but are also uniquely placed to offer a total solution for cryogenic freezing; With our extensive knowledge in the production and safe handling of liquid nitrogen, coupled with our class-leading range of MVE freezers. Whether you store on a small scale or if you need a complete cryogenic lab project managed, we provide a complete solution offering as much or as little as your business needs.

Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners across academia, biotech, and the largest biopharma, Alloy democratizes access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics across six modalities: antibodies, TCRs, genetic medicines, cell therapies, peptides, and drug delivery. Partners may access all current and future technologies through a discovery service relationship or for a flat annual fee through Alloy’s Innovation Subscriptions offering. As a reflection of Alloy’s relentless commitment to the scientific community, Alloy reinvests 100% of its revenue in innovation and access to innovation. Alloy is headquartered in Boston, MA, with labs in Cambridge, UK; Basel, CH; San Francisco, CA; and Athens, GA. To learn how to collaborate with Alloy, connect with us at: alloytx.com/contact

Alpha MD is a multi-disciplinary Healthcare and Life Sciences consultancy with offices in London, Mumbai and Philadelphia. We specialise in early stage market access; research, development and regulatory affairs; and Business Intelligence in healthcare and life sciences. This can include putting together teams for stage one or stage two trials, organising trials for medical devices, and business analytics.
We also have a doctor-patient facing app “Liberate Health” which captures everything that happens during a face to face consultation between doctor and patient, and allows the doctor to send the consultation to the patient by e mail. The patient can review the consultation as many times as they wish. This increases efficacy and patient education. Liberate is especially good for the elderly, infirm, marginalised and those with low levels of health education. Liberate also leaves an EHR.
As a part of our Pre-clinical offering, Alpha MD helps in human biospecimen procurement. We source and deliver leading edge, high quality biospecimens covering the Asian population. We specialise in the procurement of diseased and normal, fresh and frozen blood; FFPE, fresh and frozen tissue; serum, plasma, urine and other biofluids. We collect biomaterials covering all major disease targets in Oncology, Autoimmune and Metabolic disorders, Neurology, Kidney diseases, Pulmonology, Infectious diseases, OB/GYN and others.
We also work with “Clinerion”, a piece of software which is attached to an EHR and is proven to quickly identify patients for clinical trials.
Douglas Barrett – Alpha MD. douglas.barrett@sky.com
Watch our Member Showcase video here https://bit.ly/3nJdnGL

Development of new drug for the treatment of intracranial haemorrhage.

AMSBIO supplies research products and custom services to the biological and pharmaceutical industries. We sell products for routine laboratory procedures as well as more specific, cutting-edge technology. Areas of specific expertise include physiologically realistic cell culture (including 3D culture), tissues and biorepositories, Zymolyase, glycobiology, lentivirus, ELISA kits and stem cell technology. We also offer custom services in protein expression, histochemistry, peptide/antibody design and 3D culture. With offices in the UK, Germany, Switzerland and the USA, AMSBIO offers fast delivery of material. For more information, please visit www.amsbio.com or contact AMSBIO’s multilingual help team.
Watch our Member Showcase video here https://bit.ly/3HZMe9T

Longer form - Apollo Therapeutics is a collaborative venture between three world-leading UK universities (Imperial College London, UCL and the University of Cambridge) and three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Johnson & Johnson Innovation). Apollo provides committed translational funding and drug discovery expertise for novel therapeutics, sourced from the best of British academic research, accelerating them towards the clinic.. . Apollo’s unique model provides quick, independent access to the resources to grow innovations and to champion the best of British academic research to industry. Apollo’s experienced team of industry scientists have a proven track record of therapeutic delivery and work in partnership with academics and industry partners, crafting each bespoke project to optimise the chances of long-term success. Apollo Therapeutics aims to create the therapies of the future by partnering with the UK’s globally leading academic science base and UK based Pharma industry to have a real impact on patient treatments and outcomes.

Appleyard Lees is a leading intellectual property law firm with over sixty patent and trade mark attorneys and litigators.

Who we are and what we do – but also, how we do it – makes us distinctive.

We help our clients protect and monetise their intellectual property, and manage post-grant challenges, should they arise.

We offer broad sector and industry knowledge, plus the ability to adapt our services to specific client requirements, in an agile way.

With offices in UK innovation hotspots, we are positioned to give clients expert strategic IP advice in the UK and worldwide.

Pages